296 related articles for article (PubMed ID: 25791536)
1. Minimally invasive video-assisted thyroidectomy for papillary thyroid cancer: a prospective 5-year follow-up study.
Del Rio P; Maestroni U; Sianesi M; Viani L; Vicente D; Stojadinovic A; Avital I
Tumori; 2015; 101(2):144-7. PubMed ID: 25791536
[TBL] [Abstract][Full Text] [Related]
2. Comparison of surgical completeness between robotic total thyroidectomy versus open thyroidectomy.
Tae K; Song CM; Ji YB; Kim KR; Kim JY; Choi YY
Laryngoscope; 2014 Apr; 124(4):1042-7. PubMed ID: 24338236
[TBL] [Abstract][Full Text] [Related]
3. Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy.
Miccoli P; Pinchera A; Materazzi G; Biagini A; Berti P; Faviana P; Molinaro E; Viola D; Elisei R
J Clin Endocrinol Metab; 2009 May; 94(5):1618-22. PubMed ID: 19223525
[TBL] [Abstract][Full Text] [Related]
4. Minimally invasive video-assisted thyroidectomy for accidental papillary thyroid microcarcinoma: comparison with conventional open thyroidectomy with 5 years follow-up.
DI JZ; Zhang HW; Han XD; Zhang P; Zheng Q; Wang Y
Chin Med J (Engl); 2011 Oct; 124(20):3293-6. PubMed ID: 22088524
[TBL] [Abstract][Full Text] [Related]
5. Minimally invasive video-assisted thyroidectomy for papillary carcinoma: a prospective study of its completeness.
Miccoli P; Elisei R; Materazzi G; Capezzone M; Galleri D; Pacini F; Berti P; Pinchera A
Surgery; 2002 Dec; 132(6):1070-3; discussion 1073-4. PubMed ID: 12490857
[TBL] [Abstract][Full Text] [Related]
6. Video-Assisted Thyroidectomy for Papillary Thyroid Carcinoma: Oncologic Outcome in Patients with Follow-Up ≥ 10 Years.
Bellantone R; Raffaelli M; De Crea C; Sessa L; Traini E; Princi P; Lombardi CP
World J Surg; 2018 Feb; 42(2):402-408. PubMed ID: 29238849
[TBL] [Abstract][Full Text] [Related]
7. [A Meta-analysis of comparing effectiveness and safety between minimally invasive video-assisted thyroidectomy and conventional thyroidectomy in the treatment of papillary thyroid carcinoma without lymph node metastasis].
Zhang J; Yao K; Li KL
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Sep; 31(18):1435-1441. PubMed ID: 29798001
[No Abstract] [Full Text] [Related]
8. Disease outcomes and nodal recurrence in patients with papillary thyroid cancer and lateral neck nodal metastases.
O'Neill CJ; Coorough N; Lee JC; Clements J; Delbridge LW; Sippel R; Sywak MS; Chen H; Sidhu SB
ANZ J Surg; 2014 Apr; 84(4):240-4. PubMed ID: 23316684
[TBL] [Abstract][Full Text] [Related]
9. Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin.
Hughes DT; Laird AM; Miller BS; Gauger PG; Doherty GM
Ann Surg Oncol; 2012 Sep; 19(9):2951-7. PubMed ID: 22526913
[TBL] [Abstract][Full Text] [Related]
10. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment.
Soyluk O; Boztepe H; Aral F; Alagol F; Özbey NC
Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265
[TBL] [Abstract][Full Text] [Related]
11. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?
Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I
Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181
[TBL] [Abstract][Full Text] [Related]
12. The need of prophylactic central lymph node dissection is controversial in terms of postoperative thyroglobulin follow-up of patients with cN0 papillary thyroid cancer.
Korkmaz MH; Öcal B; Saylam G; Çakal E; Bayır Ö; Tutal E; Tatar EÇ
Langenbecks Arch Surg; 2017 Mar; 402(2):235-242. PubMed ID: 28224278
[TBL] [Abstract][Full Text] [Related]
13. Application of minimally invasive video-assisted technique in papillary thyroid microcarcinoma.
Gao W; Liu L; Ye G; Song L
Surg Laparosc Endosc Percutan Tech; 2013 Oct; 23(5):468-73. PubMed ID: 24105288
[TBL] [Abstract][Full Text] [Related]
14. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
15. Serial post-surgical stimulated and unstimulated highly sensitive thyroglobulin measurements in low- and intermediate-risk papillary thyroid carcinoma patients not receiving radioactive iodine.
Kashat L; Orlov S; Orlov D; Assi J; Salari F; Walfish PG
Endocrine; 2016 Nov; 54(2):460-466. PubMed ID: 27189148
[TBL] [Abstract][Full Text] [Related]
16. Minimally invasive video-assisted thyroidectomy: reflections after more than 2400 cases performed.
Miccoli P; Biricotti M; Matteucci V; Ambrosini CE; Wu J; Materazzi G
Surg Endosc; 2016 Jun; 30(6):2489-95. PubMed ID: 26335076
[TBL] [Abstract][Full Text] [Related]
17. Minimally invasive video-assisted thyroidectomy for the early-stage differential thyroid carcinoma.
Yu JJ; Bao SL; Yu SL; Zhang DQ; Loo WT; Chow LW; Su L; Cui Z; Chen K; Ma LQ; Zhang N; Yu H; Yang YZ; Dong Y; Yip AY; Ng EL
J Transl Med; 2012 Sep; 10 Suppl 1(Suppl 1):S13. PubMed ID: 23046557
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
[TBL] [Abstract][Full Text] [Related]
19. Oncologic Safety of Robot Thyroid Surgery for Papillary Thyroid Carcinoma: A Comparative Study of Robot versus Open Thyroid Surgery Using Inverse Probability of Treatment Weighting.
Sung TY; Yoon JH; Han M; Lee YH; Lee YM; Song DE; Chung KW; Kim WB; Shong YK; Hong SJ
PLoS One; 2016; 11(6):e0157345. PubMed ID: 27285846
[TBL] [Abstract][Full Text] [Related]
20. Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio.
Chang YW; Kim HS; Jung SP; Kim HY; Lee JB; Bae JW; Son GS
Int J Clin Oncol; 2016 Oct; 21(5):862-868. PubMed ID: 26837274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
